Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 13, Issue 12
|
pp. 16425–16444
Selected using bioinformatics and molecular docking analyses, PHA-793887 is effective against osteosarcoma
Back to article
Figure 6
(6 of 6)
−
100%
+
Figure 6.
Anti-osteosarcoma effects of PHA-793887 targeting CDK1.
(
A
) Results of western blot. (
B
) Relative expression of CDK1 (%Control) (
C
) CDK1 expression in MG63 cells.